Clinical Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. Jun 15, 2003; 9(6): 1365-1369
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1365
Table 1 Age distribution of patients receiving anti-ulcer drugs and age-specific prevalence of anti-ulcer drug use from 1997 to 2001
199719981999200020011997-2001
Sampling cohort
0 – 19 years573885642755448546845102952103
20 – 39 years626136376564848652196380069425
40 – 59 years398094142042922442414543247663
60 years and older209712183622489230932371526780
Total180781183448185707187237183976195971
Patients with anti-ulcer drugs
0 – 19 years2965361151714634471212339
20 – 39 years5345674192498788967323741
40 – 59 years4933621382778113866420166
60 years and older4172478759055643613214483
Total174152135228602271782918170729
Prevalence of anti-ulcer drug use
0 – 19 years5.2%6.4%9.3%8.5%9.2%23.7%
20 – 39 years8.5%10.6%14.3%13.5%15.2%34.2%
40 – 59 years12.4%15.0%19.3%18.3%19.1%42.3%
60 years and older19.9%21.9%26.3%24.4%25.9%54.1%
Total9.6%11.6%15.4%14.5%15.9%36.1%